BPC-157, TB-500, GHK-Cu, and GH peptides — what the research shows about healing and recovery
Last updated: April 2026 | Research use only — not medical advice
The peptides discussed here are research chemicals studied in laboratory and animal models for tissue repair mechanisms. None are FDA-approved treatments for injury or recovery. Human evidence varies significantly. This guide is educational. Consult a physician for any injury treatment decisions.
Tissue repair is a complex biological process involving inflammation, cell migration, angiogenesis (new blood vessel formation), collagen deposition, and remodeling. The body has natural peptide signals that orchestrate each of these phases. Research peptides that mimic or amplify these signals are studied for their potential to accelerate or improve the quality of repair — particularly for tissues that have inherently poor blood supply and slow natural healing, like tendons and ligaments.
Growth hormone (and its downstream mediator IGF-1) is the body's master anabolic signal — it drives muscle protein synthesis, activates muscle stem cells (satellite cells), and accelerates connective tissue remodeling. Age-related decline in GH is one reason recovery slows as we get older. GH-stimulating peptides address this directly.
BPC-157 is the most extensively studied repair peptide in animal models, with over 100 published studies across multiple tissue types. It derives from a partial sequence of body protection compound found in human gastric juice — which is part of why it's unusually stable and can even work when administered orally for gut-specific effects.
Tendon research: Multiple rodent models show significantly accelerated healing of Achilles tendon, patellar tendon, and medial collateral ligament injuries. The proposed mechanism involves upregulation of growth factor receptors (EGF-R, VEGFR2) and promotion of angiogenesis — creating the blood supply needed for avascular tissues to heal.
Gut research: BPC-157's most robust mechanism involves protecting and healing the gastrointestinal tract — reducing ulcers, protecting against NSAID-induced gut damage, and supporting gut barrier integrity. For athletes using NSAIDs frequently for pain management, this is a particularly relevant finding.
Human data: Phase 1/2 trials for inflammatory bowel disease have been conducted with a safety profile. Large-scale RCTs for injury repair in humans do not yet exist.
→ Full BPC-157 Price Guide (5mg from ~$33)TB-500 is a synthetic version of Thymosin Beta-4, naturally present in platelets and released at wound sites to promote healing. Its primary mechanism — promoting actin polymerization and cell motility — is fundamentally different from BPC-157, which is why the two are frequently studied in combination.
Muscle repair: TB-500's cell migration-promoting properties are particularly relevant for muscle fiber repair. It helps recruit the satellite cells (muscle stem cells) and repair cells needed to regenerate damaged muscle fibers. Research in cardiac muscle has shown impressive results — cardiomyocyte survival post-ischemia, reduced infarct size, and even some regeneration of cardiac tissue.
Systemic distribution: TB-500 distributes broadly after injection — it doesn't need to be administered near the injury site to reach damaged tissue, unlike some localized treatments. This makes it practical for multiple simultaneous repair targets.
BPC-157 + TB-500 synergy: These two peptides are complementary. BPC-157 provides localized growth factor upregulation and angiogenesis; TB-500 provides the systemic cell migration signal. Animal studies using the combination show additive benefit.
→ Full TB-500 Price Guide (10mg from $40.99)GHK-Cu is the most affordable research peptide for recovery applications on a per-mg basis. Its recovery research profile centers on collagen and elastin synthesis, angiogenesis promotion, and anti-inflammatory gene expression modulation. Its endogenous nature (the body produces it naturally and it declines with age) makes it particularly relevant for older athletes whose natural tissue maintenance capacity has declined.
Wound healing: GHK-Cu has been studied in wound healing for decades — it's one of the more established research peptides in this area. It promotes fibroblast migration and proliferation, collagen synthesis, and angiogenesis at wound sites. Both systemic and topical research exists.
Collagen quality: Beyond just stimulating collagen production, GHK-Cu appears to influence the quality and organization of collagen fibers — important for the tensile strength of repaired tendons and ligaments. This distinguishes it from peptides that simply drive inflammation-mediated repair.
→ Full GHK-Cu Price Guide (50mg from $45.99)GH peptides don't repair tissue directly — they stimulate pituitary GH release, which drives IGF-1 production, which in turn promotes muscle protein synthesis, satellite cell activation, and connective tissue remodeling. Think of them as the systemic anabolic environment that supports repair, while BPC-157 and TB-500 are the localized repair signals.
The cleanest GH stack. Ipamorelin triggers selective GH pulses with no cortisol or appetite effects; CJC-1295 primes the pituitary. The synergistic combination supports anabolic recovery without side effects. Best for sustained daily use during a recovery protocol.
CJC-1295 Price Guide →The most potent GHRP — highest GH pulse per dose. Also has direct cardiac protection via CD36, relevant for cardiovascular injury recovery. Requires cycling due to faster desensitization. Best for short, high-intensity recovery cycles.
Hexarelin Price Guide →| Peptide | Primary Mechanism | Best For | Evidence Level | Monthly Cost | Guide |
|---|---|---|---|---|---|
| BPC-157 | Growth factor upregulation, angiogenesis, NO pathway | Tendon, ligament, gut, nerve | Strong animal; limited human | $40–$120 | → |
| TB-500 | Actin polymerization, cell migration | Muscle fiber, cardiac, systemic | Strong animal; limited human | $60–$120 | → |
| GHK-Cu | Collagen synthesis, angiogenesis, gene expression | Wound healing, skin, collagen quality | Strong in vitro + cosmetic human | $33–$100 | → |
| Ipamorelin + CJC-1295 | GH → IGF-1 → satellite cells, MPS | Muscle recovery, body composition | Phase 1 + animal | $60–$120 combined | → |
| Hexarelin | GH pulse (highest) + cardiac CD36 | High-intensity GH support, cardiac | Phase 2 (cardiac) | $30–$60 | → |
| Sermorelin | GHRH → GH → IGF-1 | GH restoration for aging athletes | Phase 2/3 (GH deficiency) | $50–$150 | → |
Most peptides in this guide are prohibited by WADA for competitive athletes. TB-500 (as Thymosin Beta-4), BPC-157, and all GH peptides (Hexarelin, Ipamorelin, CJC-1295, Sermorelin) appear on the WADA Prohibited List. GHK-Cu is not currently listed but competitive athletes should verify with their sport's governing body. The prohibited status exists because these compounds can enhance performance and recovery in ways that violate the spirit of sport.
For BPC-157, both local (near the injury) and systemic (subcutaneous in the abdomen) administration show effects in animal research, but some studies suggest local administration produces more pronounced results at the specific injury site. TB-500, by contrast, distributes systemically regardless of injection site — it doesn't need to be near the injury to exert its cell migration effects throughout the body. In practice, many research protocols use subcutaneous (abdominal) injection for both compounds for simplicity, with some researchers opting for local BPC-157 injection for specific injury targets.
Animal research protocols typically run 4–12 weeks for significant tissue repair outcomes. Many researchers use a "loading" approach for the first 2–4 weeks (daily dosing at 250–500mcg) followed by a maintenance phase. BPC-157 does not appear to cause significant receptor desensitization with continuous use, unlike some GH peptides — making longer protocols more straightforward. The appropriate duration depends on the severity of the injury being studied. Unlike GH peptides, there's no established evidence of diminishing returns from extended BPC-157 use in animal models.
TB-500 is a synthetic analogue of Thymosin Beta-4 — focused on actin-binding, cell migration, and tissue repair. Thymosin Alpha-1 (Tα1) is a completely different peptide from Thymosin Beta-1, focused primarily on immune system modulation — it has been studied for immune deficiency, infections, and cancer immunotherapy. The two peptides are often confused due to the similar "Thymosin" name but have almost completely different mechanisms and research applications. TB-500 is the relevant compound for tissue repair and recovery research; Thymosin Alpha-1 is primarily an immune research peptide.
The animal model research for BPC-157 and TB-500 includes both acute injury models (freshly induced injuries) and chronic models (established damage). BPC-157 has shown effects in both contexts, which is mechanistically plausible given its role in angiogenesis — chronically damaged, poorly-vascularized tissue could theoretically benefit from the formation of new blood vessels regardless of injury age. However, the human evidence base is thin for both acute and chronic applications. The older and more established a human injury is, the more complex the repair environment, and the less predictable the peptide response is likely to be.